Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
Trading data
PILL performance and flow charts
Performance
Flows
Historic performance and flows
Data as of March 10, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | -11.30% | -8.47% | -6.07% | +60.97% | +54.24% | -53.68% |
| Flows | -$4M | -$3M | -$3M | -$4M | -$1M | +$7M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +61.01% | +69.40% | +57.20% | +61.37% |
Max drawdown | -17.70% | -45.84% | -60.51% | -85.04% |
Max drawdown duration | 13d | 148d | 375d | 1822d |
Time to recover | N/A | 132d | 226d | N/A |
Replication quality
Data as of March 12, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
PILL's exposure
This ETF provides synthetic exposure. It does not hold the securities of the index directly so we cannot display its exposure breakdown.
Characteristics
The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF is built to track the S&P Pharmaceuticals Select Industry Total Return Index - USD. This ETF provides synthetic exposure - by owning its shares you earn the return of the index indirectly through the use of derivatives or a swap.
This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Provider | Direxion |
| N° of holdings | |
| Replication method | Indirect |
| Asset class | Equities |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | November 15, 2017 |
| ESG | No |
What type of ETF is PILL?
PILL is a Passive ETF that provides exposure to Equity assets. It is managed by Direxion.
What index does PILL track?
PILL tracks the S&P Pharmaceuticals Select Industry Total Return Index - USD, aiming to replicate its performance through unfunded swap.
What does PILL invest in?
This ETF provides leveraged exposure (3x) to Equally Weighted US Pharmaceuticals Equities. It is part of the segment: Leveraged Equity.
What is the expense ratio of PILL?
The total expense ratio (TER) of PILL is 1.15%, representing the annual fee charged by the fund manager.
When was PILL launched?
PILL was launched on November 15, 2017, marking its entry into the ETF market.
Who is the issuer of PILL?
PILL is issued by Direxion.
What is the AUM of PILL?
As of March 10, 2026, PILL manages $14.40 M, reflecting the total assets held in the fund.
How has PILL performed recently?
As of March 10, 2026, PILL delivered a return of -11.3% over the past month (1M performance), -8.47% over the past three months (3M), and -6.07% year-to-date (YTD).
What are the recent fund flows for PILL?
As of March 10, 2026, PILL has seen net flows of -$4M in the past month (1M flow) and -$3M year-to-date (YTD).
Does PILL pay dividends?
As of March 10, 2026, PILL has a trailing 12-month distribution yield of 0.74%.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.
What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).
What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).
What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).
Browse all educational columns
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
